Business

E-Factor Experiences Limited Reports Stellar Financial Performance for FY 2023-24

May 30, 2024

PNN
New Delhi [India], May 30: E-Factor Experiences Limited, a premier event management and live experience creation company, has declared its financial results for the financial year 2023-24. These being first Annual results, since the company's public listing in October 2023, were announced at the board meeting held in the National Capital Region of Delhi.
Impressive Financial Highlights:
* Turnover: The company's turnover surged from Rs113.9 crore in FY 2022-23 to an impressive Rs142.1 crore in FY 2023-24, marking a significant growth trajectory.
* Profit Before Tax (PBT): E-Factor's PBT soared by over 100%, jumping from Rs9.27 crore to Rs20.0 crore, showcasing the company's robust financial health.
* Profit After Tax (PAT): The PAT witnessed a staggering increase of nearly 116%, reaching Rs14.9 crore compared to Rs6.9 crore in the previous financial year, reflecting exceptional profitability.
* Earnings Per Share (EPS): The EPS on the expanded equity is now Rs11.42, up from Rs7.18 in the previous financial year on the non-diluted equity, demonstrating strong shareholder value.
Revenue Breakdown:
* Cultural, Public Engagement, Tourism and Government Events: Contributing almost 80% of the total revenue, this segment remains the cornerstone of E-Factor's business.
* Multimedia Shows and Immersive Experiences: This segment accounted for 14% of the revenue, highlighting the company's diversification and innovative offerings.
* High-Profile Social Events: Generating about 6% of the revenue, these events underscore E-Factor's capability in managing exclusive and high-profile engagements.
Future Outlook and Dividend Proposal:
The board expressed optimism about the company's prospects for the ongoing financial year 2024-25, forecasting an impressive top-line growth of 40 to 50%. This positive outlook is expected to further solidify E-Factor's market position and enhance shareholder value.
In light of the robust financial performance, the board has recommended a 10% dividend, which will be distributed upon approval at the Annual General Meeting.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same)

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025